1 rx per primary doc is over 1 million rx's hmm
and that would put the price per share over $50. hmmm
and every doc has about 1200 to 1500 patients. hmm
and 1/3 are obese hmm
and reduces a1c in addtion to losing weight, regardless of weight loss hmm
does not cause heart racing and birth defects hmm
women that can bear children can take it hmm
no rems requirements for docs hmm
avail in pharmacies hmm
no generic equivalent available hmmm
anthem covering this drug. part of wellpoint, one of the biggest insurers in country hmm
good luck longs, shorts, cover now for under 10 or later over 20. your choice.
how many bio startups just launching their product have no debt 200 mm in cash and no dilution? this is going to be a cash cow
very very few new drug companies can ever say this. This situation is very very unique and will pay off handsomely to many many people. good luck longs, this is like buying the powerball for saturday.
second quarter, 65 million plus, the stocking of the pharmacies, plus almost 4 weeks of sales in the quarter.
it is going to be a good start. people will be amazed at the sales the first week.
your getting diluted and you are thinking shorts are in trouble? lol. i would not touch this stock with a 10 foot pole. look at how much they will have to spend on the studies required.
those are guidelines, a doc can prescribe it to anyone. they could prescribe it to someone that wants to quit chewing fingernails, or is trying to get off heroin. they can addphentermine. or whatever with it.. if it approved by fda, docs can do it.
he has an arsenal of patented unique novel drugs. he got a drug approved, the first one in over 10 years for weight loss. he has no debt. other than admiinstrative costs and minimal manufacturing cost, pure profit of 37.5 % plus milestones. This will be up there with lipitor in sales. maybe not the first year, but down the road.
If you want a carnival barker as ceo, go to vvus, and see what the debt and dilution will do to the generic combo.
I would take a guy that talks softy and sets up success for the future.
study about GPCR-focused drug discovery and Arna's patents in this area, and you will see why arna will be bought out soon, or will be one of the biggest drug companies in the world within a few years. another patent approved yesterday? awesome.
when sales start this will jump to over 50 per share. 1 million rx per year equates to a stock price of over 50 a share. It is going to be incredible. docs have been clamoring for a good weight loss drug that is safe. this is it. it also has a side affect, irregardless of weight loss, in reducing a1c in diabetics.
many on wall street will be very suprised by the out of the gate sales of belviq.
Consider the competition- a combo drug that can be prescribed as 2 generics, that races the heart and causes birth defects in 6% of babies. I would be leery to prescribe it, and if I did, I would prescribe the generics.
you are wrong. most doctors know about it and are very intriged by a diet drug that works without out the heart valve issues. people are having a very hard time losing weight and this will help.
remember 18 million phen fen rx in 1 year.
this will be huge right out the door, all the docs i know are aware and eager for it to be on the market.
I had a colonoscopy april 2 and the gastro doc said he was going to prescribe as soon as it is out.
get in now and you will have gains like aol did in 1995 96 and 97. 7 spits while i worked there.
why? wait until the end of the 30 days, then blitz the airwaves- so they see it, go to dr and then right to the pharm. if they cannot get it, why waste money?
from the q earnings " We intend to certify pharmacies and announce retail availability in the third quarter of 2013."
hes doing fine. he doesnt care about short term stock price, he is looking fwd and making this company valuable. im in under $2. he has more to do that be a carnival barker like vvus. let him focus on his job and the stock will follow. proof is in the pudding. dr vig told me about this several years ago and there are many drs that are going to rx it, and have not been rxing q. just buy and hang on and you will have a nice retirement.
may be rejected, but we will know very very soon. they would rather pay a dime now or a dollar later. let the bidding war begin. next up , eiasi with a counter offer, then maybe merk or sanofi aventis, or even JnJ
final offer may be north of 50 per share. that would equate to be only 1 million rx per year.
last short out eats it! lose a dime now or a dollar later.
many companies buy early if they are confident of success. a safe effective weight loss drug is something that has not been around before. they can pay a dime now or a dollar later. lots of pharma co's that lost blockbusters to generics, including lipitor. and many. pfizer, merk, jnj, eisai, sanofi-aventis, and others. the risk is low to the possible reward. also the pipeline arna has is incredible.